Sally Uppal

Bachelor of Medicine and Bachelor of Science,  Charité - Universitätsmedizin Berlin 

Location: United States

Consulting Services

Legal Support Journal Manuscript Biostatistics

Areas Of Interest

Aesculin Arthropathy alpha 2 Acute Phase Globulin Chemirosa, Cloretilo Raloxifene Syndrome, Cogan's Nuclear Accidents Vocal Center, High Olibanum Resin Pituitary Cushing Diseases Interleukin-23 Subunit p19 Myocardial Remodelings, Ventricular Count, Complete Blood Device, Heart-Assist Putamen, Nucleus Interleukin-2 Receptor alpha Subunit Radioisotope Brachytherapy Intra-Aortic Balloon Pumping P450 Enzyme Inhibitors Continuous Arteriovenous Hemofiltration Biomimicry Engineerings BamKI Endonuclease Ocular Toxicity Child Restraint Systems Sleep, Paroxysmal Zoophytes CD158a Antigens Incident, Chemical LF 178 Status Epilepticus, Electrographic IRL685, Fetuin-Like Protein Clinical Medicine

Professional Narrative

Dr. Sally Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 2004
Medical Writer, Amgen 2010

Education

Doctor of medicine, Yale School of Medicine 1992
Bachelor of science in nursing, Baylor College 1988

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :